What are the components of Meig's syndrome?
All of the following are associated with polycystic ovarian syndrome except?
What is the primary mode of spread in tuberculous Pelvic Inflammatory Disease?
Medical treatment of unruptured ectopic pregnancy is contraindicated in which of the following situations?
Which of the following statements about the role of laparoscopy in the diagnosis and treatment of endometriosis is FALSE?
True regarding adenomyosis is:
What is adenomyosis?
A levonorgestrel-releasing intrauterine device is advised in fibroid management if the uterine size is less than which of the following?
Miladevi is a diagnosed case of ectopic gestation, which of the following will be the most reliable indicator?
What is the gold standard for the diagnosis of Pelvic Inflammatory Disease (PID)?
Explanation: **Explanation:** **Meigs' Syndrome** is a classic clinical triad characterized by the presence of a benign ovarian tumor, ascites, and pleural effusion (hydrothorax). 1. **Why Option D is correct:** * **Fibroma of the ovary:** This is the most common benign solid tumor of the ovary associated with this syndrome. It is a sex cord-stromal tumor. * **Ascites:** The accumulation of fluid in the peritoneal cavity is a hallmark. It is thought to occur due to fluid transudation from the surface of the tumor or lymphatic obstruction. * **Hydrothorax:** This refers to pleural effusion, which is typically **right-sided** (70% of cases). The fluid moves from the abdomen to the thorax through transdiaphragmatic lymphatics or small congenital defects in the diaphragm. 2. **Why other options are incorrect:** Options A, B, and C are individual components of the syndrome. Since all three must coexist to satisfy the definition of Meigs' syndrome, "All of the above" is the only accurate choice. **High-Yield Clinical Pearls for NEET-PG:** * **Reversibility:** The defining feature of Meigs' syndrome is that both the ascites and hydrothorax **resolve spontaneously** after the surgical removal of the ovarian tumor. * **Pseudo-Meigs' Syndrome:** This term is used when the triad occurs with other pelvic masses (e.g., ovarian malignancy, leiomyoma, or germ cell tumors) instead of a benign fibroma. * **Tumor Marker:** CA-125 levels can be elevated in Meigs' syndrome, which may falsely mimic ovarian malignancy. * **Nature of Fluid:** The fluid in both the abdomen and chest is typically a **transudate**.
Explanation: **Explanation:** Polycystic Ovarian Syndrome (PCOS) is a multisystem endocrinopathy characterized by hyperandrogenism, ovulatory dysfunction, and metabolic disturbances. **Why Osteoporosis is the correct answer:** PCOS is characterized by a state of **hyperestrogenism** (due to peripheral conversion of androgens to estrone) and hyperinsulinemia. Estrogen is bone-protective as it inhibits osteoclast activity. Therefore, patients with PCOS typically have **normal or increased bone mineral density**, making osteoporosis an unlikely association. In contrast, osteoporosis is associated with hypoestrogenic states like menopause or Turner syndrome. **Analysis of incorrect options:** * **Endometrial Carcinoma:** Chronic anovulation leads to "unopposed estrogen" action on the endometrium without the stabilizing effect of progesterone. This causes endometrial hyperplasia, significantly increasing the risk of endometrial adenocarcinoma. * **Insulin Resistance:** This is a hallmark of PCOS (found in both obese and lean phenotypes). It leads to compensatory hyperinsulinemia, which stimulates the ovarian theca cells to produce more androgens and decreases Sex Hormone Binding Globulin (SHBG). * **Ovarian Carcinoma:** While the link is less direct than endometrial cancer, epidemiological studies show a moderately increased risk of certain types of ovarian cancer in PCOS patients, likely due to chronic low-grade inflammation and hormonal imbalances. **High-Yield Clinical Pearls for NEET-PG:** * **Rotterdam Criteria (2 of 3):** 1. Clinical/biochemical hyperandrogenism; 2. Oligo/anovulation; 3. Polycystic ovaries on USG (≥12 follicles or volume >10ml). * **LH:FSH Ratio:** Classically >2:1 or 3:1 (though no longer a diagnostic criterion). * **Metabolic Syndrome:** PCOS increases the risk of Type 2 Diabetes, Dyslipidemia, and Hypertension. * **First-line for ovulation induction:** Letrozole (Aromatase inhibitor).
Explanation: **Explanation:** Genital tuberculosis is almost always a secondary infection, originating from a primary focus elsewhere in the body—most commonly the lungs. **1. Why the Correct Answer is Right:** The primary mode of spread for tuberculous Pelvic Inflammatory Disease (PID) is **hematogenous (bloodstream)**. Mycobacterium tuberculosis bacilli travel from the primary pulmonary focus via the blood to the fallopian tubes. The fallopian tubes are the initial site of infection in 90-100% of cases because of their high vascularity. Once established in the tubes, the infection can then spread to the endometrium (50-60%) and ovaries (20-30%). **2. Why the Other Options are Wrong:** * **Spread through continuity/adjacent organs:** While TB can spread from the peritoneum to the tubes (descending infection), this is less common than hematogenous spread. In most cases, the peritoneum is actually involved secondary to the infected tubes. * **Spread through lymphatics:** Lymphatic spread is rare and typically occurs only if there is a primary lesion in the intestinal tract (mesenteric nodes) or very rarely from an ascending infection from the vulva/vagina. **3. NEET-PG High-Yield Clinical Pearls:** * **Most common site:** Fallopian tubes (bilateral involvement is the rule). * **Most common symptom:** Infertility (due to tubal block or "Lead pipe" appearance). * **Menstrual pattern:** Most common is oligomenorrhea or amenorrhea (due to endometrial destruction/Asherman’s syndrome), though menorrhagia can occur in early stages. * **Hysterosalpingography (HSG) findings:** "Beaded tube," "Lead pipe tube," "Tobacco pouch" appearance, and "Golf hole" ostia. * **Gold Standard Diagnosis:** Endometrial biopsy/aspirate for TB-PCR or Culture (Lowenstein-Jensen medium), preferably taken in the pre-menstrual phase.
Explanation: The medical management of ectopic pregnancy primarily involves the use of **Methotrexate (MTX)**, a folic acid antagonist. The success of this treatment depends on the viability and size of the trophoblastic tissue. ### **Explanation of the Correct Answer** **Option C (Fetal heart activity present)** is an absolute contraindication for medical management. The presence of cardiac activity indicates a highly viable and advanced pregnancy that is unlikely to respond to MTX. Such cases have a significantly higher risk of treatment failure and subsequent tubal rupture, necessitating surgical intervention (Laparoscopy). ### **Analysis of Incorrect Options** * **Option A (Sac size 3 cm):** Medical management is generally considered safe and effective if the gestational sac diameter is **< 3.5 cm or 4 cm**. A 3 cm sac falls within the inclusion criteria. * **Option B (HCG level 3000 IU):** While lower levels are preferred, MTX is typically indicated when the baseline serum β-hCG is **< 5000 mIU/mL**. A level of 3000 IU is acceptable for medical therapy. * **Option D (70 ml blood collection):** A small amount of free fluid in the pouch of Douglas (typically **< 100 ml**) is common and does not necessarily imply rupture. It is only a contraindication if there are signs of hemoperitoneum or hemodynamic instability. ### **NEET-PG High-Yield Pearls** * **Drug of Choice:** Methotrexate (inhibits Dihydrofolate Reductase). * **Absolute Contraindications:** Ruptured ectopic, hemodynamic instability, fetal cardiac activity, breastfeeding, and renal/hepatic/hematological dysfunction. * **Relative Contraindications:** β-hCG > 5000 mIU/mL, sac size > 3.5 cm, and refusal of blood transfusion. * **Monitoring:** Following MTX administration, β-hCG levels are monitored on **Day 4 and Day 7**. A drop of **≥ 15%** between Day 4 and Day 7 indicates successful treatment.
Explanation: **Explanation:** The correct answer is **C: Differentiating chocolate cyst from hemorrhagic corpus luteal cyst.** While laparoscopy is the "gold standard" for diagnosing endometriosis, it has limitations in differentiating an ovarian endometrioma (chocolate cyst) from a hemorrhagic corpus luteal cyst based on **visual inspection alone**. Both conditions present as adnexal masses containing dark, altered blood. Definitive differentiation requires **histopathological examination** (biopsy) to identify endometrial glands and stroma, which are absent in a corpus luteal cyst. **Why the other options are incorrect:** * **A. Diagnosis of peritoneal endometriosis:** Laparoscopy is the only definitive way to visualize "powder-burn" or "mulberry" lesions on the peritoneal surface, which are often missed by imaging. * **B. Management of ovarian endometrioma:** Laparoscopic cystectomy (stripping the cyst wall) is the preferred surgical treatment to reduce recurrence and improve fertility. * **D. Staging of endometriosis:** The American Society for Reproductive Medicine (ASRM) staging is based entirely on laparoscopic findings, including the size of lesions and the extent of adhesions. **Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** Laparoscopy with biopsy. * **Classic Visual Findings:** "Gunshot" or "Powder-burn" lesions (black/brown) and "Flame-shaped" lesions (red). * **Biopsy Requirement:** Histology must show at least two of the following: endometrial glands, stroma, or hemosiderin-laden macrophages (siderophages). * **Imaging:** Transvaginal Ultrasound (TVUS) is the first-line investigation for endometriomas, often showing "ground-glass" internal echoes.
Explanation: **Explanation:** Adenomyosis is a benign gynecological condition characterized by the presence of ectopic endometrial glands and stroma within the myometrium, leading to reactive hypertrophy and hyperplasia of the surrounding muscle. **Why Option C is Correct:** The classic clinical triad of adenomyosis includes **menorrhagia** (due to increased endometrial surface area and impaired uterine contractility), **secondary dysmenorrhea** (due to blood trapped within the myometrium), and a **globular, symmetrically enlarged uterus** (typically not exceeding 12–14 weeks in size). On examination, the uterus is often described as "soft and boggy." **Analysis of Incorrect Options:** * **Options A & D:** Adenomyosis is most commonly seen in **multiparous women** in their **4th and 5th decades** (ages 40–50). This contrasts with endometriosis, which is more frequent in younger, nulliparous women. The association with multiparity is thought to be due to the invagination of the basal endometrium into the myometrium during pregnancy or delivery. * **Option B:** While progestins (like the Levonorgestrel-releasing intrauterine system - LNG-IUS) are effective for symptom control, the **definitive treatment** for adenomyosis is **hysterectomy**. Unlike endometriosis, adenomyosis is often less responsive to medical therapy alone. **High-Yield Clinical Pearls for NEET-PG:** * **MRI Findings:** The "Junctional Zone" (JZ) thickness **>12 mm** is diagnostic of adenomyosis. * **USG Findings:** "Venetian blind" appearance (asymmetric shadowing) and "Rain-in-the-forest" appearance on Doppler. * **Pathology:** The definitive diagnosis is histological, showing endometrial islands >2.5 mm below the endo-myometrial junction. * **Halban’s Sign:** Tenderness of the uterus during the premenstrual period is a characteristic finding.
Explanation: ### Explanation **Adenomyosis** is a benign gynecological condition characterized by the **ectopic presence of endometrial glands and stroma within the myometrium** (the muscular layer of the uterus). This leads to reactive hypertrophy and hyperplasia of the surrounding myometrium, resulting in a symmetrically enlarged, "globular," and "boggy" uterus. #### Analysis of Options: * **Option C (Correct):** By definition, adenomyosis is the invasion of the endo-myometrial junction by basal endometrium. It is often referred to as "Endometriosis Interna." * **Option A:** Hyperplasia of endometrial glands refers to **Endometrial Hyperplasia**, a precursor to endometrial carcinoma, usually caused by unopposed estrogen. * **Option B:** Metaplasia involves the transformation of one cell type to another (e.g., squamous metaplasia of the cervix). Adenomyosis involves displacement, not cellular transformation. * **Option D:** This is anatomically incorrect; the pathology involves the inward growth of the lining into the muscle, not vice versa. #### NEET-PG High-Yield Pearls: * **Clinical Triad:** Secondary dysmenorrhea (pain), Menorrhagia (heavy bleeding), and a symmetrically enlarged, soft/boggy uterus. * **Classic Patient Profile:** Typically seen in multiparous women in their 40s and 50s. * **Diagnosis:** **MRI** is the gold standard (shows thickening of the **Junctional Zone >12 mm**). Transvaginal Ultrasound (TVUS) shows a "salt and pepper" appearance or asymmetrical myometrial thickening. * **Definitive Treatment:** Total Hysterectomy. Medical management includes Levonorgestrel-releasing Intrauterine System (LNG-IUS).
Explanation: **Explanation:** The **Levonorgestrel-releasing Intrauterine System (LNG-IUS)** is a highly effective medical management option for heavy menstrual bleeding (HMB) associated with uterine fibroids. However, its efficacy and retention depend significantly on the size and contour of the uterine cavity. **Why 12 weeks is the correct answer:** For an LNG-IUS to function effectively and remain in situ, the uterine cavity must not be significantly distorted. Clinical guidelines (including NICE and FIGO) specify that the uterine size should not exceed **12 weeks of gestation** (approximately the size of a large grapefruit). Beyond this size, the risk of **spontaneous expulsion** increases dramatically, and the hormonal distribution may be insufficient to control the enlarged endometrial surface area. Additionally, the device is primarily indicated for intramural fibroids; it is generally contraindicated if submucosal fibroids distort the cavity, regardless of uterine size. **Analysis of Incorrect Options:** * **B, C, and D (14, 16, and 20 weeks):** These sizes represent a significantly enlarged uterus that typically extends well beyond the pelvic brim. At these volumes, the uterine cavity is usually distorted or elongated beyond the reach of a standard 32mm x 32mm LNG-IUS frame, leading to high failure rates, displacement, or inability to control bleeding. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Primarily causes endometrial atrophy and thickening of cervical mucus. It reduces menstrual blood loss by ~90%. * **Ideal Candidate:** Small intramural fibroids (<3 cm) with a total uterine volume <12 weeks. * **Contraindication:** Submucosal fibroids that distort the uterine cavity (Type 0, 1, or 2). * **Other Medical Options:** If the uterus is >12 weeks, GnRH agonists or Selective Progesterone Receptor Modulators (SPRMs) like Ulipristal are preferred to shrink the volume before surgery.
Explanation: **Explanation:** The diagnosis of ectopic pregnancy relies on the concept of the **Discriminatory Zone**, which is the level of serum β-hCG at which a normal intrauterine gestational sac should be visible on ultrasound. **Why Option D is Correct:** The most reliable indicator for ectopic gestation is the **absence of an intrauterine gestational sac on Transvaginal Sonography (TVS)** when the serum β-hCG levels are above the discriminatory zone (typically >1,500–2,000 mIU/mL). If the uterus is empty at these levels, an ectopic pregnancy must be presumed until proven otherwise. This "empty uterus" sign, often combined with an adnexal mass, is the gold standard for clinical diagnosis. **Analysis of Incorrect Options:** * **A. Arias-Stella Reaction:** This is a histological change in the endometrium (hypersecretory glands with enlarged nuclei) due to hormonal stimulation. While associated with ectopic pregnancy, it is also seen in intrauterine pregnancies and even with trophoblastic disease. It is **not pathognomonic**. * **B. Culdocentesis:** This procedure detects hemoperitoneum. While blood in the Pouch of Douglas suggests a **ruptured** ectopic pregnancy, it can also occur in a ruptured corpus luteum cyst or retrograde menstruation. It is now largely replaced by USG (FAST scan). * **C. Absence of HCG Doubling:** In a healthy pregnancy, β-hCG levels should increase by at least 66% (or double) every 48 hours. A suboptimal rise suggests a non-viable pregnancy (either ectopic or an impending miscarriage), but it cannot differentiate between the two. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Ampulla of the Fallopian tube. * **Most common site for rupture:** Isthmus (occurs early, around 6–8 weeks). * **Gold Standard Investigation:** Laparoscopy (allows for both diagnosis and treatment). * **Medical Management:** Methotrexate is used if the patient is hemodynamically stable, the sac is <3.5–4 cm, and β-hCG is <5,000 mIU/mL.
Explanation: **Explanation:** **Diagnostic Laparoscopy** is considered the **gold standard** for the diagnosis of Pelvic Inflammatory Disease (PID). It allows for direct visualization of the pelvic organs, enabling the identification of characteristic signs such as tubal erythema, edema, and purulent exudate. Its primary advantage is the ability to exclude other surgical emergencies (like ectopic pregnancy or appendicitis) while allowing for the collection of peritoneal fluid for culture. **Analysis of Options:** * **Option A (Clinical Triad):** While the triad of lower abdominal pain, cervical motion tenderness, and adnexal tenderness is used for **initial clinical diagnosis** and starting empirical treatment, it has low specificity and a high false-positive rate. * **Option B (Histologic confirmation):** Endometrial biopsy showing plasma cells (endometritis) is a specific criterion but is invasive and lacks the immediate visual confirmation of tubal involvement provided by laparoscopy. * **Option D (Ultrasound):** USG is often the first-line imaging modality to rule out tubo-ovarian abscesses or other pathologies, but it lacks the sensitivity to detect mild to moderate salpingitis. **High-Yield Clinical Pearls for NEET-PG:** * **Minimum Clinical Criteria (CDC):** To prevent long-term sequelae (infertility/ectopic pregnancy), treatment is started if a patient has lower abdominal/pelvic pain AND one of the following: Cervical Motion Tenderness (Chandelier sign), Uterine tenderness, or Adnexal tenderness. * **Most Common Organism:** *Chlamydia trachomatis* (most common overall) and *Neisseria gonorrhoeae*. * **Fitz-Hugh-Curtis Syndrome:** A complication of PID involving peri-hepatitis, characterized by "violin-string" adhesions between the liver capsule and the parietal peritoneum.
Abnormal Uterine Bleeding
Practice Questions
Endometriosis
Practice Questions
Adenomyosis
Practice Questions
Uterine Fibroids
Practice Questions
Ovarian Cysts
Practice Questions
Pelvic Inflammatory Disease
Practice Questions
Vulvovaginitis
Practice Questions
Pelvic Organ Prolapse
Practice Questions
Vulvar Disorders
Practice Questions
Benign Breast Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free